Krystal Biotech, Inc.KRYSNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank89
3Y CAGR+11.1%
5Y CAGR+44.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+11.1%/yr
vs +86.8%/yr prior
5Y CAGR
+44.9%/yr
Recent deceleration
Acceleration
-75.7pp
Decelerating
Percentile
P89
Within normal range
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $199.06M | -2.8% |
| 2024 | $204.76M | +30.1% |
| 2023 | $157.33M | +8.4% |
| 2022 | $145.20M | +112.7% |
| 2021 | $68.28M | +119.2% |
| 2020 | $31.15M | +41.1% |
| 2019 | $22.08M | +85.3% |
| 2018 | $11.92M | +149.7% |
| 2017 | $4.77M | +317.5% |
| 2016 | $1.14M | - |